Genomes and Genes
blood group incompatibility
Summary: A mismatch between donor and recipient blood. Antibodies present in the recipient's serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
Publications224 found, 100 shown here
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donorsJames M Gloor
Division of Nephrology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Transplantation 75:971-7. 2003..Given the scarcity of cadaveric organs, efforts are intensifying to increase the availability of living donors. The current study assessed the feasibility of using ABO-incompatible living-donor kidneys to expand the donor pool...
- Xenotransplantation and ABO incompatible transplantation: the similarities they shareUri Galili
Department of Medicine, University of Massachusetts Medical School, LRB, Worcester, MA 01605, USA
Transfus Apher Sci 35:45-58. 2006..Such tolerance is perpetuated indefinitely by the subsequent transplantation of the organ expressing the incompatible blood group antigen...
- Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factorsD Toki
Department of Urology, Tokyo Women s Medical University, Tokyo, Japan
Am J Transplant 9:567-77. 2009....
- Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST)Nancy M Heddle
Department of Medicine and McMaster Transfusion Research Program, McMaster University, and Canadian Blood Services, Hamilton, Ontario, Canada
Transfusion 52:1687-95. 2012..A qualitative study was undertaken to understand this process from the perspective of those who administer blood products and to identify concerns and suggestions to improve safety...
- Clinical outcome of ABO-incompatible living unrelated donor kidney transplantationJunji Uchida
Department of Urology, Osaka City University Graduate School of Medicine, 1 4 3 Asahi machi, Abeno Ku, Osaka, Japan
Urol Int 86:307-14. 2011..ABO-incompatible living unrelated donor kidney transplantation is an immunologically high-risk procedure, but few reports have been made on the outcomes of these transplants...
- RHD positive haplotypes in D negative EuropeansF F Wagner
Abteilung Transfusionsmedizin, Universitatsklinikum Ulm and DRK Blutspendedienst Baden Württemberg, Institut Ulm, Ulm, Germany
BMC Genet 2:10. 2001..Excluding RHDpsi and CdeS frequent only in individuals of African descent, most of these alleles are unknown and the population frequency of any such allele has not been determined...
- Red blood cell alloimmunization in sickle cell disease: prevalence in 2010Scott T Miller
State University of New York Downstate Medical Center Kings County Hospital Center, Brooklyn, NY 11203, USA
Transfusion 53:704-9. 2013..Transfusion of red blood cells (RBCs) is frequently required for care of individuals with sickle cell disease (SCD). Alloimmunization rates are high and may be reduced by matching for RBC antigens that can cause alloimmunization...
- ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantationGeorg Stussi
Department of Internal Medicine, University Hospital, Basel, Switzerland
Transfus Apher Sci 35:59-69. 2006In contrast to solid organ transplantation (SOT), ABO-histo blood group incompatibility is of minor importance for hematopoietic stem cell transplantation (HSCT)...
- Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibilityYi Hao Weng
Division of Neonatology, Department of Pediatrics, Chang Gung Children s Hospital, Taipei, Chang Gung University College of Medicine, Taoyuan, Taiwan
Chang Gung Med J 32:400-8. 2009..In the current study, we investigate the spectrum and outcome of marked neonatal hyperbilirubinemia with blood group incompatibility.
- Plasma exchange conditioning for ABO-incompatible renal transplantationJ L Winters
Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Apher 19:79-85. 2004..Controlled clinical trials are needed to identify the optimum conditioning for ABO-incompatible renal transplants...
- ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodiesCassandra D Josephson
Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Transfus Apher Sci 42:83-8. 2010..The progress in this European strategy may serve the US to stimulate a re-examination of its practices and policies for the advancement of platelet transfusion safety...
- MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in miceRichard T Strait
Division of Emergency Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
J Exp Med 208:2525-44. 2011..These observations have important implications for the prevention and treatment of TRALI...
- The role of immunomodulation in ABO-incompatible adult liver transplant recipientsLucio Urbani
Liver Transplant Unit, Azienda Ospedaliero Universitaria Pisana, Ospedale Cisanello, Pisa, Italy
J Clin Apher 23:55-62. 2008....
- Biliary complications after 52 adult living donor liver transplantations: a single-center experienceH Iwamoto
5th Department of Surgery, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan
Transplant Proc 40:2539-41. 2008..The incidence of biliary complications after adult living donor liver transplantation (ALDLT) are still high even though various devices have been reported to overcome them...
- ABO-incompatible kidney transplantationMark D Stegall
Department of Surgery, Division of Transplantation Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Transplantation 78:635-40. 2004..Here we review the therapeutic options for patients whose only living kidney donor is ABO incompatible, with a specific emphasis on the rationale for and the current outcomes of ABO incompatible living donor kidney transplantation...
- Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantationKoichi Kozaki
Department of Transplantation Immunology, Faculty of Medicine, Kyoto University, Kyoto, Japan
Ther Apher Dial 9:285-91. 2005..In this article, we describe our therapeutic strategy and the role of apheresis around ABO-incompatible LDLT...
- [ABO-incompatible liver transplantation for liver failure]Yang Yang
Liver Transplant Center, Third Affiliated Hospital of Sun Yat Sen University, Transplantation Research Institute of Sun Yat sen University, Guangzhou 510630, China
Zhonghua Yi Xue Za Zhi 87:2833-6. 2007..To evaluate the efficacy of ABO-incompatible orthotopic liver transplantation (OLT) in treatment of liver failure...
- Present status of ABO-incompatible living donor liver transplantation in JapanHiroto Egawa
Japanese registry working group, Division of Liver Transplantation, Japan Study Group for ABO Blood Type Incompatible Transplantation, Japan
Hepatology 47:143-52. 2008....
- ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysisZoe A Stewart
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Liver Transpl 15:883-93. 2009..Liver Transpl 15:883-893, 2009. (c) 2009 AASLD...
- Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case reportY Nakamura
Fifth Department of Surgery, Tokyo Medical University, Tokyo, Japan
Transplant Proc 36:2269-73. 2004..We report a successful case of adult ABO-incompatible liver transplantation with the use of an intrahepatic artery infusion...
- Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresisThomas Heffron
Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322, USA
Liver Transpl 12:972-8. 2006..In conclusion, our outcomes may support the concept of using ABO-I grafts in a more elective setting associated with split and living donor liver transplants...
- Successful ABO-incompatible liver transplantation using A2 donorsU Skogsberg
Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
Transplant Proc 38:2667-70. 2006..We herein have reported our experience with ABO-incompatible liver transplantation using A(2) donors to blood group O recipients...
- Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibilityH Yoshida
Department of Transfusion Medicine, Kyoto University Hospital, Japan
Transfusion 34:702-5. 1994..The infant did not require an exchange transfusion and is now a healthy 2-year-old boy. CONCLUSION: This therapeutic method is very useful in the management of fetomaternal P-incompatibility...
- Islet cell autoantibodies in cord blood from children with blood group incompatibility or hyperbilirubinemiaA Maria Elfving
Department of Pediatrics, Lund University, Lund, Sweden
Autoimmunity 36:111-5. 2003b>Blood group incompatibility is a risk factor for type 1 diabetes...
- Clinical outcomes of ABO-incompatible RBC transfusionsKim A Janatpour
Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento 95817, USA
Am J Clin Pathol 129:276-81. 2008..Prompt recognition and discontinuation of the transfusion are critical because transfusing less ABO-incompatible blood may minimize signs and symptoms and may prevent death...
- Molecular testing for transfusion medicineConnie M Westhoff
American Red Cross, Philadelphia, Pennsylvania 19130, USA
Curr Opin Hematol 13:471-5. 2006..This review summarizes the progress made in the last decade in applying genotyping to prenatal practice and clinical transfusion medicine...
- Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitorsP A Arndt
American Red Cross Blood Services, Pomona, CA 90006, USA
Transfus Med 15:125-32. 2005..We suggest that babies born to mothers with anti-Ge should have their haemoglobin concentrations monitored for signs of anaemia for several weeks after birth. Functional assays may prove useful...
- Liver transplantation across Rh blood group barriers increases the risk of biliary complicationsJuli Busquets
Department of Surgery, Hospital Universitari de Bellvitge, Barcelona, Spain
J Gastrointest Surg 11:458-63. 2007..An ABO-incompatible blood group has also been suggested as a factor for predisposal towards BC. However, the influence of Rh nonidentity has not been studied previously...
- Prenatal genotyping of the Duffy blood group system by allele-specific polymerase chain reactionM J Hessner
The Diagnostic Laboratories of The Blood Center, Milwaukee, WI 53233, USA
Prenat Diagn 19:41-5. 1999..This assay is particularly useful for rapid genotyping of fetal amniotic cells to identify pregnancies at risk for HDN due to maternal fetal incompatibilities within the Duffy blood group system...
- [An experience of ABO-incompatible kidney transplantation using plasmapheresis and anti-CD20 monoclonal antibody]Hee Won Moon
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Korean J Lab Med 29:585-8. 2009..The kidney transplantation was successful without any sign of hyperacute or acute rejection...
- Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantationH Ishida
Department of Surgery III, Tokyo Women s Medical University, Japan
Transplantation 70:681-5. 2000..Here, the pre- and posttransplantation anti-AB titers in patients who received transplants from ABO-incompatible living donors are reviewed and the pathological findings are compared...
- Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantationMary E Fidler
Department of Laboratory Medicine, Division of Anatomic Pathology, Mayo Foundation and Clinic, Rochester, MN, USA
Am J Transplant 4:101-7. 2004..Glomerular thrombi appear early in AMR and may appear prior to graft dysfunction...
- Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policyC D Josephson
Transfusion Medicine Program, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Transfusion 44:805-8. 2004..Based on these data, a policy was instituted to test anti-A/A,B titers in O SDPs prior to "out-of-group" transfusion...
- A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantationJames M Gloor
Department of Nephrology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Transplantation 80:1572-7. 2005....
- Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell diseaseM A Reyes
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston, TX 77030, USA
Immunohematology 24:45-51. 2008..To the best of our knowledge, this is the first published case of hyperhemolysis in sickle cell disease attributable to anti-Fy3...
- First two AB-incompatible living kidney transplantations in the Balkans--should it be a procedure of choice in a developing country?G B Spasovski
Department of Nephrology, University Clinical Center, University of Skopje, Macedonia
Int J Artif Organs 30:173-5. 2007....
- Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation--single center analysisH Ishida
Department of Urology, Tokyo Women s Medical University, Tokyo, Japan
Am J Transplant 7:825-31. 2007..001). We conclude that the FK/MMF combination regimen provides excellent graft survival results in ABO-ILKT...
- Blood group antibodies and their significance in transfusion medicineJoyce Poole
International Blood Group Reference Laboratory, Bristol, UK
Transfus Med Rev 21:58-71. 2007..However, deciding on the clinical significance of an antibody when compatible blood is not immediately available is likely to remain as one of the most common dilemmas facing transfusion practitioners...
- Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allograftsA B Collins
Department of Pathology, Medical and Surgical Services of Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
Transplant Proc 38:3427-9. 2006..This may account for some of the HLA antibody negative cases that develop antibody-mediated rejection...
- Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in JapanKota Takahashi
Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
Am J Transplant 4:1089-96. 2004..We conclude that long-term outcome in recipients of ABO-incompatible living kidneys is excellent. Transplantation of ABO-incompatible kidneys from living donors is a radical, but effective treatment for end-stage renal disease...
- [ABO-incompatible renal transplantation]Kazunari Tanabe
Nihon Jinzo Gakkai Shi 46:411-8. 2004
- Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplantMark K Fung
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania, USA
Transfusion 44:1635-9. 2004..Approximately 10 percent of ABO-compatible liver transplants involve a D- donor and a D+ recipient...
- Impact of positive PRA on the results of ABO-incompatible kidney transplantationH Shimmura
Department of Urology, Tokyo Women s Medical University, Tokyo, Japan
Transplant Proc 36:2169-71. 2004..It is well known that highly sensitized patients with positive panel reactive antibodies (PRA) often present with acute rejection. Therefore, we examined the impact of a positive PRA on the results of ABO-incompatible LKT...
- Impact of HLA-identity on results of ABO-incompatible living kidney transplantationH Shimmura
Department of Urology, Tokyo Women s Medical University, Tokyo, Japan
Transplant Proc 36:2172-4. 2004..However, the impact on HLA-identity on the results of ABO-incompatible living donor kidney transplantation had not been investigated previously...
- Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppressionHiroaki Shimmura
Department of Urology, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
Transplantation 80:985-8. 2005..In conclusion, no correlation between anti-A/B antibody titers and the results of ABO-incompatible LKT was seen after tacrolimus or mycophenolate mofetil application...
- [Current status and future perspectives of living kidney transplantation from ABO-incompatible or spousal donors]Kazunari Tanabe
Department of Urology, Graduate School of Medicine, Tokyo Women s Medical School, Tokyo, Japan
Nihon Geka Gakkai Zasshi 106:659-62. 2005
- [Diego blood system and the antibodies]Hatsue Tsuneyama
Japanese Red Cross Tokyo Blood Center
Nihon Rinsho 63:692-4. 2005
- The Dutch national living donor kidney exchange programMarry de Klerk
Department of Internal Medicine Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Am J Transplant 5:2302-5. 2005..For optimal results, both ABO blood type incompatible and cross match positive pairs should participate...
- Pediatric heart transplantation across ABO blood type barriers: a case studyRose J Rodriguez
Children s Hospital of New York Presbyterian, New York, NY, USA
Prog Transplant 15:161-5. 2005..This article presents a case study of a neonate with congenital heart disease who underwent one of the first successful ABO-incompatible heart transplantations in the United States...
- Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetilMakoto Mannami
Department of Urology, Uwajima Tokushukai Hospital, 2 6 24 Sumiyoshi, Uwajima 798 0003, Japan
Transplantation 79:1756-8. 2005..The administration of MMF 4 weeks before kidney transplant effectively inhibits B-cell function, suggesting a potential role for MMF in the prevention of humoral rejection...
- ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatmentGunnela Nordén
Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Goteborg, Sweden
Xenotransplantation 13:148-53. 2006..No splenectomy was performed. Eight recipients received one dose of anti-CD20 mAb (rituximab, 375 mg/m2) pre-operatively and 11 recipients had postoperative protocol IA...
- Titres of alloantibodies against A and B blood types in non-pedigree domestic cats in Turkey: assessing the transfusion reaction riskMehmet Gurkan
Department of Surgery, Faculty of Veterinary Medicine, Kirikkale University, Kirikkale, Turkey
J Feline Med Surg 7:301-5. 2005..4% and premature red cell destruction in 83.3%. Transfusion of type A or B blood to type AB cats results in no apparent clinical transfusion reactions...
- Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years laterJean Paul Squifflet
Department of Kidney and Pancreas Transplantation and Organ Procurement, Saint Luc Hospital, University of Louvain Medical School, 10 Hippocrate Avenue, B 1200 Brussels, Belgium
Exp Clin Transplant 2:208-13. 2004..As the procedure remains unchanged, it might be reserved to patients where cadaver graft could not be a valuable alternative, especially for recipients < 15 years of age with a living related ABO-incompatible donor...
- Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsyK Sugiyama
Department of Nephrology, Toho University Omori Hospital, Tokyo, Japan
Transplant Proc 37:701-4. 2005..However, there has been no clear definition of histpathological criteria for DHAR after ABO-incompatible kidney transplantation. The definition must prognosticate whether the rejection process is reversible...
- Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantationJ M Gloor
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, Minnesota, USA
Am J Transplant 6:1841-7. 2006..Thus, although HR is associated with an increase in TG, in its absence allograft histology is similar in +XM, ABOI and conventional allografts 1 year posttransplant...
- Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivativesChristoph Buchta
Department Transfusion Medicine, University Clinic for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Biologicals 33:41-8. 2005..For harmonization of standards for anti-A and anti-B in plasma-derived therapeutics the regulators and manufacturers will have to realistically deal with complex clinical, practical, and economic issues...
- Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantationJason Schwartz
Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, MN 55905, USA
Transplantation 82:155-63. 2006..These protocols lead to an increase in resource utilization and cost of transplantation and may result in increased complications...
- ABO-incompatible transplantation--a safe way to perform renal transplantation?Jorg Beimler
Nierenzentrum Heidelberg, Department of Nephrology, University of Heidelberg, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany
Nephrol Dial Transplant 22:25-7. 2007
- Improved graft survival in ABO-incompatible living donor kidney transplantationS Kaihara
Department of Transplantation and Regenerative Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
Transplant Proc 37:1804-5. 2005..We reviewed ABO-incompatible living donor kidney transplantations (LDKT) performed in our institute...
- Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatchSebastian Scholl
Department of Internal Medicine II, Oncology and Hematology, Friedrich Schiller University, Jena, Germany
Transfusion 45:1676-83. 2005..Major ABO mismatch can lead to different clinical problems including acute hemolysis after infusion of the allograft, delay of red blood cell (RBC) engraftment, or even manifestation of pure red cell aplasia (PRCA)...
- Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantationHiroto Egawa
Department of Transplantation Immunology, Faculty of Medicine, Kyoto University, Kyoto, Japan
Transplantation 77:403-11. 2004..The aim of the present study was to evaluate the outcome of liver transplants performed with ABO-incompatible living-donor livers and to detect risk factors for development of complications...
- Beneficial effect of antibody removal and enhanced immuno suppression in flow cytometry cross match-positive and ABO-incompatible renal transplantationA Katayama
Kidney Center, Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan
Transplant Proc 34:2771-2. 2002
- The risk of transfusion to the wrong patient in GermanyGregor Caspari
Transfusion 42:1238-9. 2002
- Anti-Vel reactivity diminished by adsorption with rabbit RBC stromaSteven A Mechanic
Department of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, Pennsylvania, USA
Transfusion 42:1180-3. 2002..Anti-Vel is an antibody to an antigen of high prevalence...
- New choices for patients needing kidney transplantation across antibody barriersRob Higgins
Transplant Unit, University Hospitals Coventry and Warwickshire, Coventry, West Midlands, UK
J Ren Care 34:85-93. 2008..It is likely that both schemes will complement each other and both are available in the United Kingdom...
- ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgeryNeil Blumberg
Transfusion 42:1527-8; author reply 1528-9. 2002
- Hydrops foetalis caused by anti-Mur in first pregnancy--a case reportK H Wu
China Medical College Hospital, Taichung, Taiwan
Transfus Med 12:325-7. 2002..The polymerase chain reaction-restriction fragment length polymorphism method confirmed that both the baby and her father had the Mi.III gene. Therefore, our report documents that anti-Mur has the potential to cause hydrops foetalis...
- ABO incompatible renal transplantation in an HIV-seropositive patientMaya Campara
Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA
Transplantation 86:176-8. 2008..Antibody-mediated rejection was not observed on biopsy. The patient reached a serum creatinine nadir of 2.0 mg/dL on postoperative day 20, which has now been maintained for 170 days. His current CD4 count was 410 cells/microL...
- Exchange living-donor kidney transplantation: merits and limitationsKyu Ha Huh
Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea
Transplantation 86:430-5. 2008..After the success of the direct exchange donor (swap) program in Korea since 1991, we have developed a swap-around program. However, reports on the long-term outcomes of exchange donor programs are scarce...
- Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantationNithya S Krishnan
Renal Department, University Hospitals Coventry and Warwickshire NHS Trust, United Kingdom
Transplantation 86:474-7. 2008..The method allowed quantitative discrimination in the range of antibody levels relevant to ABO incompatible transplantation and has the advantages over HA of objective measurement and reproducibility...
- Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implicationsOswaldo Castro
Department of Internal Meidicine, Howard University College of Medicine, Washington, DC, USA
Transfusion 42:684-90. 2002..Transfusing only phenotype-matched RBCs has been recommended to reduce the incidence of alloimmunization to blood group antigens in patients with sickle cell disease (SCD)...
- Results of kidney transplantation from ABO-incompatible living donors in a single institutionT Kenmochi
Department of Surgery, Chiba East National Hospital, National Hospital Organization, Chiba, Japan
Transplant Proc 40:2289-91. 2008..8%). Total patient survival at 3 years was 95.2%, and graft survival at 3 years was 90.5%, which were almost equal to those in the patients who underwent ABO-matched, compatible kidney transplantation...
- Transplantation of ABO-incompatible and living unrelated donor-recipient combinationsN Ishikawa
Division of Renal Surgery and Transplantation, Department of Urology, Jichi Medical University School of Medicine, Tochigi, Japan
Transplant Proc 40:2292-3. 2008..9%) kidneys were donated from spouses (husband/wife) and 174 (20.9%) from ABO-incompatible donors. This study summarized our experience of ABO-incompatible and living unrelated, especially spousal kidney transplantation...
- Donor anti-Jk(a) causing hemolysis in a liver transplant recipientMara Hareuveni
Sourasky Medical Center, Tel Aviv, Israel
Transfusion 42:363-7. 2002..Passenger lymphocyte syndrome occurs when immunocompetent donor lymphocytes transferred during transplantation produce alloantibodies against host antigens...
- Steroid avoidance: is it ready for prime time?Martin L Mai
Transplantation 86:897-8. 2008
- Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusionsBanu Aygun
Division of Pediatric Hematology Oncology, Schneider Children s Hospital, New Hyde Park, NY, USA
Transfusion 42:37-43. 2002....
- Short-term results in ABO-incompatible living related kidney transplantationT Kawase
Department of Surgery, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
Transplant Proc 34:2773. 2002
- Minor ABO-incompatible living-related lung transplantationY Sano
Department of Surgery II, Okayama University Medical School, Okayama, Japan
Transplant Proc 34:2807-9. 2002
- Expanding the living organ donor pool: positive crossmatch and ABO incompatible renal transplantationMary Jo Holechek
Adult Abdominal Organ Transplant Service, Johns Hopkins Hospital, Baltimore, MD, USA
Nephrol Nurs J 30:195-204. 2003..Many patients have willing live donors who are excluded from donation due to a positive crossmatch or blood group incompatibility. Plasmapheresis and intravenous immunoglobulin in combination can efficiently remove antibodies against ..
- Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantationNaoki Kawagishi
Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University, Sendai, Japan
Ther Apher Dial 11:319-24. 2007....
- Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejectionDaisuke Morioka
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan
Transplantation 85:171-8. 2008..The clinical symptoms, histological findings, and treatments for antibody-mediated rejection (AMR), which is the leading cause of graft loss in adult ABO-incompatible liver transplantation (ABO-I-LT), have rarely been discussed...
- Impact of selected factors on early graft function in patients after renal transplantationJ Sienko
Department of Surgery and Transplantation, Pomeranian University of Medicine, Szczecin, Poland
Transplant Proc 35:2167-9. 2003..The study showed that a high maximal PRA level, incompatibility for ABO group, and a longer warm ischemia time increase the probability of early graft function disorders...
- Five years of single-center experience with paired kidney exchange transplantationM Lucan
Clinical Institute of Urology and Renal Transplantation, 4 6 Clinicilor Str, 400006 Cluj Napoca, Romania
Transplant Proc 39:1371-5. 2007..Even if there are still some unanswered questions, this program is current in some centers, and there appears to be a tendency to extend it in Europe. The aim of our study was to assess our results with PKEP after 5 years...
- Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantationsGunnar Tyden
Departments of Transplantation Surgery and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden
Transplantation 83:1153-5. 2007..A new protocol for ABO-incompatible kidney transplantation has recently been introduced. We report here on the joint experience of the implementation in Stockholm and Uppsala, Sweden and Freiburg, Germany...
- Therapeutic apheresis therapy for ABO-incompatible renal transplantationsHideki Ishida
Department of Urology, Division of Blood Purification, Tokyo Women s Medical University, Tokyo, Japan
Ther Apher Dial 7:520-8. 2003..In this article, we describe the historical background, the current therapeutic strategies including apheresis therapy for the ABO-incompatible transplantations, and the experiences at our institution...
- Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriersDaniel S Warren
The Department of Surgery, The Johns Hopkins University School of Medicine, Balitmore, Maryland, USA
Am J Transplant 4:561-8. 2004..The ability to cross these two barriers simultaneously is clinically important as sensitized patients have often exhausted their blood type compatible living donors during previous transplants...
- The impact of delayed graft function on graft survival in living donor kidney transplantationO J Kwon
Transplantation Unit, Hanyang University Hospital, Seoul, South Korea
Transplant Proc 35:92-3. 2003
- Current status of liver transplantation across ABO blood-type barrierHiroto Egawa
Organ Transplant Unit, Kyoto University Hospital, 54 Kawara cho, Shogoin, Sakyo ku, Kyoto 606 8507, Japan
J Hepatobiliary Pancreat Surg 15:131-8. 2008..The outcome is now similar to that of blood-type-matched transplantation. However, there are still issues to be solved in order to further improve the outcome via a decrease of infection...
- Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCsFouad N Boctor
Department of Pathology, Blood Bank and Transfusion Service, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
Transfusion 43:173-6. 2003..D- patients with AIDS may require blood transfusion and, during times of blood shortage, may receive D+ RBCs. They would be expected to become alloimmunized to the d antigen...
- Double filtration plasmapheresis in an ABO-incompatible renal transplantation: a case reportH Kawamura
Department of Urology, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan
Transplant Proc 35:227-9. 2003
- An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibilityS Umit Sarici
Division of Neonatology, Department of Pediatrics, Hacettepe University Faculty of Medicine Ihsan Doğramaci Children s Hospital, Ankara, Turkey
Pediatrics 109:e53. 2002....
- Bilirubin dosage in cord blood: could it predict neonatal hyperbilirubinemia?Adélia Jeha Nasser Bernaldo
Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Sao Paulo Med J 122:99-103. 2004..With early discharge, many newborns have to be readmitted to hospital for hyperbilirubinemia to be treated, and this has been held responsible for the reappearance of kernicterus...
- Neonatal anemia associated with Southeast Asian ovalocytosisVichai Laosombat
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla, Thailand
Int J Hematol 82:201-5. 2005..were premature infants, an infant with congenital syphilis, low-birth-weight infants, infants with ABO blood group incompatibility, infants with 3-thalassemia, infants with hemoglobin E heterozygote or homozygotes, glucose-6-phosphate ..
- ABO incompatible kidney transplantation - an analysis of UNOS Registry dataYasuro Futagawa
Terasaki Foundation Laboratory, Los Angeles, CA 90064, USA
Clin Transplant 20:122-6. 2006..However, there are few reports to support the feasibility of ABO incompatible transplants from non-A2 deceased donors. This problem was examined in the United Network for Organ Sharing (UNOS) data file...
- Time-dependent risk factors influencing the long-term outcome in living renal allografts: donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantationH Toma
Department of Urology, Tokyo Women s Medical University, Shinjuku ku, Tokyo, 162 8666 Japan
Transplantation 72:940-7. 2001..Most investigations have revealed that the improvement in early graft survival has not resulted in a corresponding improvement in long-term graft survival. The risk factors for long-term graft survival should be clarified...
- Distinguishing between recurrent primary sclerosing cholangitis and chronic rejectionAnthony Jake Demetris
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
Liver Transpl 12:S68-72. 2006..Technical problems with biliary reconstruction, long cold ischemic times, non-heart beating donors, ABO blood group incompatibility, antibody-mediated rejection, and small-for-size syndrome in reduced-size or living donor livers can ..
- [Therapeutic apheresis: selective methods]Petar Kes
Zavod za dijalizu, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
Acta Med Croatica 62:49-59. 2008..They are useful in renal transplantation for cases with positive crossmatch or AB0 blood group incompatibility, as well as for treatment of acute humoral rejection...
- Factors related to the durability of a homograft monocusp valve inserted during repair of tetralogy of Fallot as based on the mid- to long-term outcomesJi Hyuk Yang
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Cardiol Young 18:141-6. 2008..In this study, we have evaluated the mid- to long-term outcomes, aiming to determine the durability of the homograft...
- Intrahepatic cholestasis after liver transplantationZiv Ben-Ari
Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
Liver Transpl 9:1005-18. 2003..for hepatotoxicity, intrahepatic biliary strictures, chronic rejection, hepatic artery thrombosis, ABO blood group incompatibility, and recurrent disease...
- Congenital haemolytic anaemia in a low birth weight infant due to congenital stomatocytosisP S Huppi
Department of Obstetrics and Gynaecology, University of Berne, Switzerland
Eur J Haematol 47:1-9. 1991..There was no blood group incompatibility between mother and child but there was a marked stomatocytosis of the baby's red blood cells...
- Immune hemolysis associated with transplantationLawrence D Petz
StemCyte International Cord Blood Center, Arcadia, CA 91007, USA
Semin Hematol 42:145-55. 2005..One of the important causes is the passenger lymphocyte syndrome, which occurs following minor ABO blood group incompatibility between donor and recipient...
- Improvement in Paired Donation ProgramStanislaw M Stepkowski; Fiscal Year: 2013..the transplantation of kidneys from living donors who otherwise are not transplanted because of ABO blood group incompatibility and/or the presence of donor-specific antibodies (Abs;DSA) in sensitized patients...
- ICAM1 gene inactivation protects against ischemic injuryRobert Montgomery; Fiscal Year: 2006..This work has important implications for the selective inactivation of gene function in allografts through ex vivo gene transfer. ..
- Erythrocyte Complement Receptor 1 in Transfusion/MalariaKarina Yazdanbakhsh; Fiscal Year: 2005....
- VLA4 IN CTL MEDIATED ISLET ALLOGRAFT REJECTIONMark Stegall; Fiscal Year: 2001..The approach may lead to novel forms of immune suppression that may benefit not only islet transplantation, but also other types of organ allografts. ..
- Selective depletion of alloreactive T cells in BMTJAMES ZIMRING; Fiscal Year: 2005..In keeping with the stated purpose of this RFA, these studies represent the "development and application of cell engineering methods to predictably induce tolerance..." ..
- The role of Ach in CD8+ Cytolytic T cell developmentJAMES ZIMRING; Fiscal Year: 2005..abstract_text> ..
- Development of an ABO Incompatibility Stop Device (AISD)Christopher Hillyer; Fiscal Year: 2008..If the unit is not compatible, the transfusion is not allowed to proceed. This should stop all mistransfusion and the related deaths. [unreadable] [unreadable] [unreadable]..
- Induction of Immunological Tolerance for Gene TherapyJAMES ZIMRING; Fiscal Year: 2008..unreadable] [unreadable] [unreadable] [unreadable] [unreadable]..
- "Development of a Laboratory Test for TTP"Christopher Hillyer; Fiscal Year: 2003..abstract_text> ..
- Genetics of Anorexia NervosaBernie Devlin; Fiscal Year: 2006..The diagnostic and genetic data and lymphoblastoid cell lines (derived from blood samples) will become part of a national archival resource for genetic studies of AN through the NIMH Genetics Initiative. ..
- Alloimmunization to mHAs by RBC TransfusionJAMES ZIMRING; Fiscal Year: 2007..By analyzing transfusion patients at Emory, we will determine the extent to which females receiving leukoreduced RBC from male donors are immunized to H-Y antigens. [unreadable] [unreadable] [unreadable]..
- CD8 + CD75s + regulatory T cells in anti-tumor immunityJAMES ZIMRING; Fiscal Year: 2007..These aims propose to investigate the role that negative regulatory T cells play in the establishment of immunological tolerance to tumor antigens and the fashion in which their elimination can result in tumor rejection. ..
- Genetics of Schizophrenia in Oceanic Palau.Bernie Devlin; Fiscal Year: 2010..Molecular and fine-mapping studies will identify risk loci. We believe this study is unique among studies of Scz genetics for its population, sample, the research team and the novelty of hypotheses and approach. ..
- Genomic Approaches to Improve Transfusion Therapy in SCD PatientsMarion E Reid; Fiscal Year: 2010..We believe that data generated from this project will have an immediate impact in improving the transfusion of patients with SCD. (End of Abstract) ..
- INCREASE/gp120 IMMUNOGENICITY/LINKED ALPHA-GAL EPITOPESUri Galili; Fiscal Year: 2005..We will then also collaborate with a group studying immune responses in monkeys to determine the efficacy of this vaccine in a primate model. ..
- NEWBORN GENETIC SCREENING:FOR WHOSE BENEFIT?Lainie Ross; Fiscal Year: 2005..OUTCOMES: The major outcomes will be a series of peer-reviewed articles and a full-length book entitled Newborn Genetic Screening: In whose Interest? For whose Benefit? ..
- RH PROTEIN AND THE RH BLOOD GROUP SYSTEMChen Han Huang; Fiscal Year: 2004..The knowledge gained will also deepen our understanding of clinical problems associated with the RH blood group system, allowing the clinical service to explore new approaches for their management. ..
- MONOCLONAL ITP AUTOANTIBODIES--PARADIGM FOR AUTOIMMUNITYDonald Siegel; Fiscal Year: 2002..Ultimately, the proposed approach may be applied to the understanding of other autoimmune disorders. ..
- PCR Screening for CMV in Umbilical Cord Blood Stem CellsChristopher Hillyer; Fiscal Year: 2003....
- TRANSFUSION TRANSMISSION OF CELL-ASSOCIATED INFECTIONSChristopher Hillyer; Fiscal Year: 2003..He predicts that allogeneic leukocyte interactions mediate reactivation of MCMV in the recipient and that g IFN inhibits this process. ..
- RhBG and RhcG Proteins in Nonerythroid TissuesChen Han Huang; Fiscal Year: 2005..The results obtained should contribute to understanding the structure, function and regulation of the Rh family, revealing a potentially important, new homeostatic mechanism operative in human and mammalian organs. ..
- REPORTING SYSTEM TO IMPROVE SAFETY OF THE BLOOD SUPPLYHarold Kaplan; Fiscal Year: 2002..The validation and continued operation of MERS-TM is an appropriate response to the public's interest and to meet the needs of transfusion medicine. ..
- Xenograft-like rejection of tumors in a-gal glycolipidsURI GALILI GALILI; Fiscal Year: 2010..We will study this treatment in a unique mouse model that simulates the pertinent human immunological parameters. Success in the studies in the mouse model will enable us to apply this treatment to cancer patients. ..
- PREVENTING ANTI-GAL PRODUCTION AGAINST XENOGRAFTSUri Galili; Fiscal Year: 2003..Success in these studies will help in planning effective treatments for preventing anti-Gal response in primate xenografts recipients. | ..
- Phage Display Tools for Automated Blood TypingDonald Siegel; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- Pediatric Clinical Research Scholar Program - WashingtonNaomi Luban; Fiscal Year: 2007..abstract_text> ..
- Schizophrenia Liability Genes among African AmericansBernie Devlin; Fiscal Year: 2006..Finally, we have an outstanding track record of African American participation in research studies, and a deep appreciation of their population genetics. ..
- DECIPHERING THE FUNCTION OF THE RH BLOOD GROUP PROTEINSConnie Westhoff; Fiscal Year: 2002..These studies will lead, not only to an understanding of Rh function, but also to an explanation of the clinical effects that occur when this function is disrupted. ..
- Admixture Mapping Schizophrenia Genes in Oceanic PalauBernie Devlin; Fiscal Year: 2006..Collaborating sites are the University of Pittsburgh (Devlin), Carnegie Mellon University (Roeder, subcontract to Pitt) and University of California Irvine (Byerley). ..